These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35723775)

  • 1. The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study.
    Atila C; Monnerat S; Urwyler SA; Refardt J; Winzeler B; Christ-Crain M
    Pituitary; 2022 Aug; 25(4):636-644. PubMed ID: 35723775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.
    Urwyler SA; Lustenberger S; Drummond JR; Soares BS; Vogt DR; Ammer N; Yuen KCJ; Ribeiro-Oliveira A; Christ-Crain M
    Pituitary; 2021 Aug; 24(4):555-563. PubMed ID: 33615399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmotic stimulation of vasopressin acutely impairs glucose regulation: a counterbalanced, crossover trial.
    Jansen LT; Suh H; Adams JD; Sprong CA; Seal AD; Scott DM; Butts CL; Melander O; Kirkland TW; Vanhaecke T; Dolci A; Lemetais G; Perrier ET; Kavouras SA
    Am J Clin Nutr; 2019 Dec; 110(6):1344-1352. PubMed ID: 31562496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
    Atila C; Gaisl O; Vogt DR; Werlen L; Szinnai G; Christ-Crain M
    Eur J Endocrinol; 2022 May; 187(1):65-74. PubMed ID: 35521789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin levels in response to pituitary provocation tests in healthy volunteers.
    Sailer CO; Winzeler B; Urwyler SA; Schnyder I; Refardt J; Eckert A; Varghese N; Fassnacht M; Chifu I; Lawson EA; Verbalis JG; Fenske W; Christ-Crain M
    Eur J Endocrinol; 2021 Aug; 185(3):355-364. PubMed ID: 34181566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
    Winzeler B; Cesana-Nigro N; Refardt J; Vogt DR; Imber C; Morin B; Popovic M; Steinmetz M; Sailer CO; Szinnai G; Chifu I; Fassnacht M; Christ-Crain M
    Lancet; 2019 Aug; 394(10198):587-595. PubMed ID: 31303316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon.
    Lundegaard Asferg C; Bjørn Andersen U; Linneberg A; Goetze JP; Holst JJ; Jeppesen JL
    Diabet Med; 2019 Nov; 36(11):1408-1411. PubMed ID: 30242900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of copeptin during a model of experimental pain and hyperalgesia: A randomised volunteer crossover trial.
    Mauermann E; Blum CA; Lurati Buse G; Bandschapp O; Ruppen W
    Eur J Anaesthesiol; 2017 May; 34(5):306-314. PubMed ID: 28106611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copeptin under glucagon stimulation.
    Lewandowski KC; Lewiński A; Skowrońska-Jóźwiak E; Stasiak M; Horzelski W; Brabant G
    Endocrine; 2016 May; 52(2):344-51. PubMed ID: 26578365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Arginine and Insulin Stimulation Elicits a Robust and Consistent Copeptin Response in Short Children.
    March CA; Sastry S; McPhaul MJ; Wheeler SE; Garibaldi L
    Horm Res Paediatr; 2023; 96(4):395-403. PubMed ID: 36513057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.
    Canivell S; Mohaupt M; Ackermann D; Pruijm M; Guessous I; Ehret G; Escher G; Pechère-Bertschi A; Vogt B; Devuyst O; Burnier M; Martin PY; Ponte B; Bochud M
    J Endocrinol Invest; 2018 Jul; 41(7):799-808. PubMed ID: 29235050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress.
    Kacheva S; Kolk K; Morgenthaler NG; Brabant G; Karges W
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):570-6. PubMed ID: 25200793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans.
    Enhörning S; Tasevska I; Roussel R; Bouby N; Persson M; Burri P; Bankir L; Melander O
    Eur J Nutr; 2019 Feb; 58(1):315-324. PubMed ID: 29242971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine-stimulated copeptin in children and adolescents.
    Binder G; Weber K; Peter A; Schweizer R
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):548-553. PubMed ID: 36710502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin.
    Enhörning S; Vanhaecke T; Dolci A; Perrier ET; Melander O
    Sci Rep; 2021 Dec; 11(1):24481. PubMed ID: 34966186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas.
    Abu-Basha EA; Yibchok-Anun S; Hsu WH
    Metabolism; 2002 Sep; 51(9):1184-90. PubMed ID: 12200765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men.
    Asferg CL; Andersen UB; Linneberg A; Goetze JP; Jeppesen JL
    Diabet Med; 2014 Jun; 31(6):728-32. PubMed ID: 24533694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
    Boertien WE; Meijer E; Li J; Bost JE; Struck J; Flessner MF; Gansevoort RT; Torres VE;
    Am J Kidney Dis; 2013 Mar; 61(3):420-9. PubMed ID: 23089511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay.
    Katan M; Morgenthaler NG; Dixit KC; Rutishauser J; Brabant GE; Müller B; Christ-Crain M
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2640-3. PubMed ID: 17426098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects.
    Varaldo E; Bioletto F; Cuboni D; Prencipe N; Bona C; Barale M; Ghigo E; Grottoli S; Berton AM; Gasco V
    Eur J Endocrinol; 2023 Mar; 188(3):. PubMed ID: 36757796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.